CD4 and B-cell chronic lymphocytic leukemia: In conclusion, in vitro as well as xenograft experiments suggest that CD4+ T-cells enhance CLL cell survival and proliferation, which is supported by correlations of CD4+ T-cell counts and clinical outcome.